Literature DB >> 3875287

Non-group A beta-hemolytic streptococcal cellulitis. Association with venous and lymphatic compromise.

L M Baddour, A L Bisno.   

Abstract

Cellulitis occurring in the limbs of patients who have previously undergone saphenous venectomy and coronary bypass surgery has been the subject of several recent reports. Although isolation of pathogenic microorganisms from these lesions has been uncommon, this report describes three patients who had undergone venectomy previously and in whom non-group A beta-hemolytic streptococci were recovered either during acute episodes of cellulitis or during quiescent intervals. There are to date only four other reported cases of post-venectomy cellulitis from which beta-hemolytic streptococci were isolated: one was non-group A and the others were not serologically characterized. Moreover, studies in patients without bypass who have experienced cellulitis in extremities with compromised venous and/or lymphatic circulation have also yielded a substantial number of non-group A streptococci. The data thus far implicate non-group A beta-hemolytic streptococci as a major cause of cellulitis, especially in the setting of circulatory compromise.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3875287     DOI: 10.1016/0002-9343(85)90003-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  19 in total

1.  Optimal management of uncomplicated skin and skin structure infections of the lower extremity.

Authors:  Warren S Joseph
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

2.  Management and morbidity of cellulitis of the leg.

Authors:  N H Cox; G B Colver; W D Paterson
Journal:  J R Soc Med       Date:  1998-12       Impact factor: 5.344

3.  Susceptibility of bacterial isolates from complicated skin and skin structure infections to cefazolin, imipenem-cilastatin, ciprofloxacin and ofloxacin.

Authors:  H H Liu; N K Bolash; M E McAnany; R A Lynch
Journal:  Drugs       Date:  1995       Impact factor: 9.546

4.  Recent considerations in recurrent cellulitis.

Authors:  Larry M Baddour
Journal:  Curr Infect Dis Rep       Date:  2007-10       Impact factor: 3.725

5.  Group B streptococcal soft tissue infections beyond the neonatal period.

Authors:  J M McCarty; J Haber
Journal:  West J Med       Date:  1987-11

6.  Warmer Weather as a Risk Factor for Cellulitis: A Population-based Investigation.

Authors:  Ryan A Peterson; Linnea A Polgreen; Daniel K Sewell; Philip M Polgreen
Journal:  Clin Infect Dis       Date:  2017-10-01       Impact factor: 9.079

7.  Beta-hemolytic streptococcal erythroderma syndrome: a clinical and pathogenic analysis.

Authors:  Harmony L Tyner; Patrick M Schlievert; Larry M Baddour
Journal:  Am J Med Sci       Date:  2011-10       Impact factor: 2.378

8.  Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema.

Authors:  S R Harris; M R Hugi; I A Olivotto; M Levine
Journal:  CMAJ       Date:  2001-01-23       Impact factor: 8.262

9.  Murine model of recurrent group G streptococcal cellulitis: no evidence of protective immunity.

Authors:  A L Bisno; J M Gaviria
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

10.  Fluoroquinolone therapy for uncomplicated skin and skin structure infections : a retrospective database comparison of treatment duration, failures and charges.

Authors:  Karen N Keating; Howard Friedman; Eleanor M Perfetto
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.